Antifungal Agents Flashcards

1
Q

What is the most common fungal pathogen?

A

candida

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are fungal pathogens?

A

candida, aspergillus, zygomycetes, endemic fungi, cryptococcus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does candida cause?

A

mild infections such as oropharyngeal or esophgeal candidiasis, uncomplicated candiduria, and vulvovaginal candidiasis
serious invasive diseases such as catheter-associated infections and disseminated disease (invasive candidiasis refers to severe forms of disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are risk factors for invasive candidiasis?

A

prolonged stay in ICU; central venous catheters; prolonged therapy with broad spectrum antibacterial agents; receipt of parenteral nutrition; recent surgery; hemodialysis; DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Increased mortality if empiric antifungal therapy is delayed by how many hours?

A

12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is aspergillus?

A

mold ubiquitous in the environment
primarily causes disease in immunocompromised hosts (neutropenia)
pulmonary system most common infection
definitive diagnosis requires positive culture from sterile site but can also use histologic/radiologic evidence in high-risk pt with negative cultures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are zygomycetes?

A

rhizopus, absidia, mucor, rhizomucor
most commonly seen as sinus infection
risk factors: DM, immunosuppression!, penetrating injuries from natural disasters
definitive diagnosis: tissue invasion on histopathologic exam with or without microbiologic evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is endemic fungi?

A

may cause disseminated disease via primary pulmonary infection
higher risk in pts with suppressed cell-mediated immunity
histoplasma capsulatum and blastomyces species found in IN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is cryptococcus?

A

species found in IN: cryptococcus neoformans
encapsulated yeast that primarily affects the CNS and respiratory tract
more common in pts who are infected with HIV, have received organ transplants, or high-dose corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the spectrum of activity of amphotericin B?

A

1st line: cryptococcus, blastomyces, histoplasma, mucor
commonly used as initial agent in systemic invasive fungal infections such as histoplasmosis/blastomyces and cryptococcal meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Facts about amphotericin B

A

poorly absorbed after PO administration - requires IV
not appreciably metabolized (just naturally goes away)
renal and hepatic impairment and hemodialysis do NOT affect drug clearance (no dose adjustments)
lipid formulations –> 80-90% reduction in kidney concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the dosing for amphotericin B?

A

deoxycholate: usual 0.5-1 mg/kg/day (fewer adverse events if administered as continuous infusion over 24h)
liposomal: most commonly 3-5mg/kg daily
lipid complex: 5mg/kg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the adverse effects of amphotericin B?

A

infusion related reactions: pretreat with acetaminophen, antihistamines
nephrotoxicity - can cause increase in SCr and BUN
electrolyte abnormalities: hypokalemia, hypomagnesemia
anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to prevent nephrotoxicity in amphotericin B?

A

0.5-1L normal saline over 30 min before AMB and 0.5-1L normal saline after completion of infusion; hydration!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are facts about flucytosine?

A

great bioavailability
penetrates into CSF - main use is combo therapy with amphoB for cryptococcal meningitis
TDM to adjust dose: goal peak concentration 70-80 mcg/mL, trough concentrations 20-40 mcg/mL
85-95% excreted unchanged in urine (renally dose adjusted)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the spectrum of activity of flucytosine?

A

1st line for cryptococcus
candida

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the dosing of flucytosine?

A

25 mg/kg/dose po q6h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the adverse effects of flucytosine?

A

GI
hematologic: bone marrow suppression (because it’s converted to 5-FU)
monitor: CBC, platelets, SCr, BUN

19
Q

Ketoconazole

A

metabolized by the liver
not renally dose adjusted!

20
Q

What are the adverse effects of ketoconazole?

A

GI, hepatotoxicity, endocrine (gynecomastia, decreased libido, oligospermia, loss of hair, menstrual irregularities)

21
Q

What is the clinical use of ketoconazole?

A

shoule never be used orally for first-line therapy of any fungal infection due to risk of hepatotoxicity and drug interactions
mostly used topically for tinea infections

22
Q

What is the spectrum of activity of ketoconazole?

A

candida albicans, cryptococcus, histoplasma

23
Q

Fluconazole

A

bioavailability >90%
decent CSF concentration
excreted unchanged in urine - dose reduce in renal insufficiency
dosing based on TOTAL body weight
inhibitor of CYP2C9 and CYP3A4

24
Q

What is the clinical use of fluconazole?

A

1st line for invasive candidiasis: if C. albicans - 800mg (12mg/kg) loading dose, then 400mg (6mg/kg) daily; if C. glabrata - 800mg daily (loading dose 1200-1600mg)
noninvasice candidiasis, prophylaxis in BMT, cryptococcal meningitis

25
Q

What are the adverse effects of fluconazole?

A

QTc prolongation!!!
HA, nausea, anorexia, adrenal insufficiency, elevation of hepatic transaminases

26
Q

What is the spectrum of activity of fluconazole?

A

1st line: candida albicans, candida parapsilosis, candida tropicalis, candida lusitaniae, coccidioides
cryptococcus

27
Q

Itraconazole

A

metabolized by CYP450 3A4 isoenzyme
active metabolite: hydroxyitraconazole
clearance decreases with higher doses due to saturable hepatic metabolism
no dose adjustment for renal dysfunction
absorption dependent on gastric acidity: capsules better absorbed with meal or acidic cola; oral solution better absorbed in fasting state (not affected by gastric acidity)

28
Q

What are the clinical uses of itraconazole?

A

1st line: histroplasmosis - 200mg PO TID x 3days, then 200mg PO BID; blastomycosis

29
Q

What are the adverse effects of itraconazole?

A

hepatotoxicity, congestive heart failure (boxed warning), QTc prolongation
contraindicated in pregnancy and CHF
serum trough itraconazole concentrations > 0.5-1 mcg/mL; troughs >1.5 mcg/mL combined itraconazole and hydroxyitraconazole associated with efficacy, >3 mcg/mL –> increased AEs

30
Q

What is the spectrum of activity of itraconazole?

A

1st line: blastomyces and histoplasma
C. albicans, C. parapsilosis, cryptococcus, coccidioides, aspergillus

31
Q

Posaconazole

A

oral suspension - absorption affected by gastric pH
delayed release tabs - preferred oral formulation, absorption not affected by gastric pH
both better absorbed when taken with food
IV formulation contains cyclodextrin - AVOID if CrCl < 50mL/min

32
Q

What are the adverse effects of posaconazole?

A

QTc prolongation!!
N/V/D, abdominal pain, increased AST/ALT/bilirubin, hypokalemia, rash, pseudohyperaldosteronism

33
Q

What is the spectrum of activity of posaconazole?

A

C. albicans, C. parapsilosis, C. lusitaniae, cryptococcus, blastomyces, histoplasma, coccidioides, aspergillus, mucor

34
Q

Voriconazole

A

significantly metabolized by CYP450 isoenzymes (2C19, 2C9, 3A4)
no dose adjustment necessary for ORAL dosing; AVOID IV if ClCr < 50mL/min due to accumulation of vehicle
absorption not affected by H2 antagonists, PPI, antacids

35
Q

What is the clinical use of voriconazole?

A

invasive aspergillosis!
candidemia and other deep tissue candida infections, esophageal candidiasis
dosing based on ideal body weight of adjusted body weight

36
Q

What are the adverse effects of voriconazole?

A

visual disturbances!, elevated liver function tests, QTc prolongation, phototoxic skin reactions, diffuse painful periostitis

37
Q

What is the spectrum of activity of voriconazole?

A

very broad
1st line: aspergillus
C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C. lusitaniae, C. auris, cryptococcus, blastomyces, histoplasma, coccidioides

38
Q

Isavuconazole

A

good oral bioavailability
no dosage adjustment for renal impairment or ESRD
IV formulation does NOT contain cyclodextrin

39
Q

What is the clinical use of isavuconazole?

A

invasive aspergillus or mucor (usually last line therapy)
this is pro-drug

40
Q

What are the adverse effects of isavuconazole?

A

N/V/D, HA, hepatic, infusion related reactions (d/c if occurs), hypokalemia, hypersensitivity and severe skin reactions
does NOT cause QTc prolongation (can actually shorten)! - use in pts with prolonged QTc

41
Q

What are the drug interactions of isavuconazole?

A

overall considered to be the least DI in the azole family
contraindicated with familial short QT syndrome

42
Q

What is the spectrum of activity of isavuconazole?

A

very broad
C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C. lusitaniae, C. auris, cryptococcus, blastomyces, histoplasma, coccidioides, aspergillus, mucor

43
Q

Overall was are the class adverse effects of azoles?

A

hepatic dysfunction
QTc prolongation (except isavuconazole)
GI intolerance
many drug interactions - because of hepatic elimination

44
Q

What drug has the greatest spectrum of activity?

A

isavuconazole > voriconazole > posaconazole > itraconazole > fluconazole > ketocontazole